India · Delayed Price · Currency is INR Thyrocare Technologies Statistics
Total Valuation
NSE:THYROCARE has a market cap or net worth of INR 92.98 billion. The enterprise value is 91.60 billion.
| Market Cap | 92.98B |
| Enterprise Value | 91.60B |
Important Dates
The next estimated earnings date is Thursday, December 10, 2026.
| Earnings Date | Dec 10, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
| Current Share Class | 159.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +2.50% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 25.90% |
| Float | 77.96M |
Valuation Ratios
The trailing PE ratio is 52.74 and the forward PE ratio is 42.83.
| PE Ratio | 52.74 |
| Forward PE | 42.83 |
| PS Ratio | 10.61 |
| PB Ratio | 15.87 |
| P/TBV Ratio | 19.63 |
| P/FCF Ratio | 48.34 |
| P/OCF Ratio | 43.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.47, with an EV/FCF ratio of 47.62.
| EV / Earnings | 51.96 |
| EV / Sales | 10.46 |
| EV / EBITDA | 32.47 |
| EV / EBIT | 40.88 |
| EV / FCF | 47.62 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | 0.26 |
| Interest Coverage | 65.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 37.91% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.79% |
| Revenue Per Employee | 4.60M |
| Profits Per Employee | 924,974 |
| Employee Count | 1,906 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:THYROCARE has paid 548.00 million in taxes.
| Income Tax | 548.00M |
| Effective Tax Rate | 23.75% |
Stock Price Statistics
The stock price has increased by +37.77% in the last 52 weeks. The beta is 0.46, so NSE:THYROCARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +37.77% |
| 50-Day Moving Average | 564.62 |
| 200-Day Moving Average | 469.56 |
| Relative Strength Index (RSI) | 49.61 |
| Average Volume (20 Days) | 858,158 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:THYROCARE had revenue of INR 8.76 billion and earned 1.76 billion in profits. Earnings per share was 11.05.
| Revenue | 8.76B |
| Gross Profit | 4.82B |
| Operating Income | 2.22B |
| Pretax Income | 2.31B |
| Net Income | 1.76B |
| EBITDA | 2.61B |
| EBIT | 2.22B |
| Earnings Per Share (EPS) | 11.05 |
Balance Sheet
The company has 1.90 billion in cash and 506.90 million in debt, with a net cash position of 1.39 billion.
| Cash & Cash Equivalents | 1.90B |
| Total Debt | 506.90M |
| Net Cash | 1.39B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.86B |
| Book Value Per Share | 36.79 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 2.13 billion and capital expenditures -208.80 million, giving a free cash flow of 1.92 billion.
| Operating Cash Flow | 2.13B |
| Capital Expenditures | -208.80M |
| Depreciation & Amortization | 391.55M |
| Net Borrowing | -183.90M |
| Free Cash Flow | 1.92B |
| FCF Per Share | n/a |
Margins
Gross margin is 54.96%, with operating and profit margins of 25.36% and 20.12%.
| Gross Margin | 54.96% |
| Operating Margin | 25.36% |
| Pretax Margin | 26.33% |
| Profit Margin | 20.12% |
| EBITDA Margin | 29.83% |
| EBIT Margin | 25.36% |
| FCF Margin | 23.20% |
Dividends & Yields
This stock pays an annual dividend of 9.33, which amounts to a dividend yield of 1.65%.
| Dividend Per Share | 9.33 |
| Dividend Yield | 1.65% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | 1.25% |
| Earnings Yield | 1.90% |
| FCF Yield | 2.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:THYROCARE is 663.00, which is 13.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 663.00 |
| Price Target Difference | 13.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 18.52% |
| EPS Growth Forecast (3Y) | 24.21% |
Stock Splits
The last stock split was on November 28, 2025. It was a forward split with a ratio of 3.
| Last Split Date | Nov 28, 2025 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |